We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

The SonALAsense logo
Product News

SonALAsense Announces Completion of First Cohort in Phase 2 Study of Sonodynamic Therapy for Recurrent Glioblastoma

SonALAsense has announced that the first cohort in Sonodynamic Therapy (SDT)-202 was fully enrolled.
The Personalis logo
Product News

Personalis Selected for Clinical Research After Successful Evaluation of Residual Disease Assay

Personalis, Inc. has announced it will continue its collaboration with AstraZeneca to explore ultra-sensitive molecular residual disease measurement, including clinically relevant and personalized variant tracking, for clinical research and drug development.
Three circular images of the AML mouse model.
Product News

TransCure bioServices Delivers CDX Mouse Models To Advance AML Preclinical Studies

TransCure bioServices has developed cell line-derived xenograft mouse models that will change how researchers tackle the preclinical studies of cancer therapies to treat acute myeloid leukemia.
Syringe and three vials of vaccine.
Product News

Voltron Therapeutics, Inc. Announces Sponsored Research Agreement With the Massachusetts General Hospital, Harvard Medical School, To Initiate a Pre-Clinical Immuno-Oncology Trial

Voltron Therapeutics, Inc. has signed a new Sponsored Research Agreement with the Vaccine and Immunotherapy Center at Massachusetts General Hospital, Harvard Medical School to initiate a pre-clinical immuno-oncology trial targeting prostate stem cell antigen in prostate, renal cell and urothelial cancers, adding important potential indications to its growing pipeline.
The Akamis Bio logo
Product News

Akamis Bio, Parker Institute for Cancer Immunotherapy and Cancer Research Institute Expand Partnership

Akamis Bio has announced an expansion of its ongoing partnership with the Parker Institute for Cancer Immunotherapy to include a clinical collaboration with the Cancer Research Institute that will focus on advancing novel treatments for pancreatic cancer.
The Cytek Biosciences logo
Product News

Cytek® Biosciences Partners With Bio-Rad To Expand Reagent Portfolios

Delivering a boost to immuno-oncology and immunotherapy researchers, Cytek Biosciences, Inc. has announced that it has entered into a strategic partnership with Bio-Rad Laboratories, Inc.
Flow chart of 3D and thermal imaging workflow and results.
Product News

TransCure bioServices Offers BioVolume 3D Imaging

The new service is a world first in 3D imaging, allowing the measurement and visualization of tumor growth in animal models across preclinical research, oncology and drug development.
Two hands holding jigsaw pieces representing a partnership.
Product News

Personalis and Moderna Sign New Agreement To Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials

The platform will be used to sequence genomic information from a patient’s tumor sample to identify the unique genetic mutations that are most likely to generate a tailored antitumor response.
Dr Alastair Smith, Chief Executive Officer of Avacta Group.
Product News

Avacta Announces Successful Completion of Fourth Dose Escalation in Phase 1 Clinical Study

Avacta Group plc announces that AVA6000 continues to show a very favorable safety profile in the fourth dose cohort of the ALS-6000-101 dose escalation phase 1 clinical trial.
The Mainz Biomed logo
Product News

Mainz Biomed Enrolls First Patient in eAArly DETECT Study Evaluating Integration of Novel mRNA Biomarkers Into ColoAlert

Mainz Biomed NV has announced the first patient has been enrolled in eAArly DETECT, Mainz’s U.S. extension of ColoFuture, its European feasibility study evaluating the integration of a portfolio of novel gene expression (mRNA) biomarkers into ColoAlert.